# Exelixis: Phase 3 cabinet pivotal trial evaluating cabozanitib
**FDA Update**

**2023-10-22 06:50**

**https://www.ainvest.com/news/exelixis-phase-3-cabinet-pivotal-trial-evaluating-cabozanitib-231010002825252e7bc6e0ba/**

Exelixis: Phase 3 cabinet pivotal trial evaluating cabozanitib